Microban International is leveraging its expertise in antimicrobial technologies for polymers to look for synergistic effects to help medical device manufacturers address bacterial contamination of medical devices commonly associated with healthcare-acquired infections (HAIs).Â
"Our experience with a broad range of antimicrobial technologies and materials puts us in a unique position to be able to help medical device manufacturers get to market more quickly with more effective technologies," says Dr. Ivan Ong, vice president of research and development for Microban International.
The company has recently made significant advances in the development of antimicrobial solutions for acetal (POM), a material commonly used in catheter tubing and connector components which can be a source of HAIs. Acetals are prone to processing issues with many additives, causing chemical degradation and formaldehyde off-gassing in the final product. A new antimicrobial solution has been developed that is compatible with acetal and causes no destabilization or formaldehyde generation. Microbans findings show effective performance with greater than 4-log reductions against a wide variety of organisms using the companys standard, enhanced and human-serum based testing protocols.Â
This new work is a significant step forward and will help medical device manufacturers to offer an antimicrobial solution that is more robust and provides more consistent antimicrobial performance, Ong says.Â
Microban provides comprehensive development support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance. For more information, visit http://www.microban.com/microban-medical.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.